Please login to the form below
Ethan Knowlden leaves Novartis for Complete Genomics
Joins genome sequencing firm as senior VP, general counsel
Complete Genomics has appointed Ethan Knowlden as the company's new senior VP, general counsel.
Knowlden joins from Novartis Vaccines and Diagnostics, where he was VP of business development and licensing, and corporate counsel. He spent more than 13 years at Novartis and its predecessor Chiron Corp.
In his new role, he will provide legal advice to Complete Genomics, which is a US subsidiary of the China-based genomics firm BGI-Shenzhen.
Complete Genomics is one of the leading companies working in human genomic sequencing, having sequenced more than 15,000 whole human genomes.
"Whole human genome sequencing will dramatically change the way in which healthcare is practiced in many countries during the next decade and I am delighted to be part of the Complete team at this transformative time," said Knowlden.
Featured jobs
-
Associate Director
-
£75, 000-90, 000
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Account Director, Medical Education
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Medical Writer
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Business Director
-
Competitive Salary Offered
-
Account Director
-
Competitive Salary Offered
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Senior Account Manager
-
Competitive Salary Offered
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
- Global Business Development Director – Health Education
-
excellent commission
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Account Manager / Account Director
-
Competative
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Novartis forges AI alliance with Oxford University
- FDA adcomm split on Sanofi’s type 1 diabetes drug
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
PMHub
Publicis Resolute
Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
